Form D · Other
Pura Sanguine, L.L.C.
Angleton, TX · CIK 0002150142
Offering snapshot reported Aug 13, 2026 · SEC filing
- Reported sold
- $100K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jul 31, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2026 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594125
Issuer Direct Sales.
Source: Form D, filed Aug 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Terry Dobson | Director, Executive |
| Wesley Godwin | Director, Executive |
| Dan Holland | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
4023 Technology Drive
Angleton, TX, 77515
Angleton, TX, 77515